CLDI Latest Press Releases

-- October 27, 2026 --

Calidi Biotherapeutics Presented New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026, Including Highlighting the Potential of its RedTail Gene Medicine Platform to Turn Tumors into Localized TCE Biofactories Globe Newswire 8:00 AM

-- October 19, 2026 --

Calidi Biotherapeutics to Present New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026 Globe Newswire 8:00 AM

-- September 25, 2026 --

Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency Globe Newswire 5:00 PM

-- September 17, 2026 --

Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering Globe Newswire 9:10 AM

-- September 8, 2026 --

Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference Globe Newswire 8:00 AM

-- August 13, 2026 --

Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights Globe Newswire 4:30 PM

-- July 27, 2026 --

Calidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Conference Globe Newswire 8:00 AM

-- July 21, 2026 --

Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers Globe Newswire 8:00 AM

-- July 20, 2026 --

Calidi Announces Reverse Stock Split, Expected to Begin Trading on a 1-for-16 Split Adjusted Basis on July 31, 2026 Globe Newswire 4:30 PM

-- July 8, 2026 --

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 Globe Newswire 4:05 PM

-- June 24, 2026 --

Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit Globe Newswire 8:00 AM

-- June 23, 2026 --

Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors Globe Newswire 8:00 AM

-- June 16, 2026 --

Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study Globe Newswire 8:00 AM

-- June 8, 2026 --

Calidi Biotherapeutics Announces Investor Webinar on June 9, 2026 Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes